Patents Examined by Meear Natarajan
  • Methods of treatment using anti-erbb antibody-maytansinoid conjugates
    Patent number: 8093358
    Abstract: The application concerns methods of treatment using anti-ErbB receptor antibody-maytansinoid conjugates, and articles of manufacture suitable for use in such methods. In particular, the invention concerns ErbB receptor-directed cancer therapies, using anri-ErbB receptor antibody-maytansinoid conjugates.
    Type: Grant
    Filed: December 3, 2007
    Date of Patent: January 10, 2012
    Assignee: Immunogen, Inc.
    Inventors: Walter Blättler, Ravi V. J. Chari